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Background: Visual sensory processing deficits are consistently observed in schizophre-
nia, with clear amplitude reduction of the visual evoked potential (VEP) during the initial
50–150 ms of processing. Similar deficits are seen in unaffected first-degree relatives and
drug-naïve first-episode patients, pointing to these deficits as potential endophenotypic
markers. Schizophrenia is also associated with deficits in neural plasticity, implicating dys-
function of both glutamatergic and GABAergic systems. Here, we sought to understand
the intersection of these two domains, asking whether short-term plasticity during early
visual processing is specifically affected in schizophrenia.
Methods: Brief periods of monocular deprivation (MD) induce relatively rapid changes
in the amplitude of the early VEP – i.e., short-term plasticity. Twenty patients and 20
non-psychiatric controls participated. VEPs were recorded during binocular viewing, and
were compared to the sum of VEP responses during brief monocular viewing periods (i.e.,
Left-eye+Right-eye viewing).
Results: Under monocular conditions, neurotypical controls exhibited an effect that
patients failed to demonstrate.That is, the amplitude of the summed monocular VEPs was
robustly greater than the amplitude elicited binocularly during the initial sensory processing
period. In patients, this “binocular effect” was absent.
Limitations: Patients were all medicated. Ideally, this study would also include first-episode
unmedicated patients.
Conclusion: These results suggest that short-term compensatory mechanisms that allow
healthy individuals to generate robust VEPs in the context of MD are not effectively acti-
vated in patients with schizophrenia. This simple assay may provide a useful biomarker of
short-term plasticity in the psychotic disorders and a target endophenotype for therapeutic
interventions.
Keywords: EEG, psychosis, visual evoked potential, event-related potential, endophenotype, genetic liability,
biomarker, vision
INTRODUCTION
Visual sensory processing deficits have been consistently docu-
mented in schizophrenia using the visual evoked potential (VEP)
method (1–7). These deficits, which manifest as substantial reduc-
tion in amplitude of the early P1 component of the VEP, represent
a potentially promising endophenotypic marker insofar as healthy
first-degree biological relatives of schizophrenia patients show
entirely similar attenuation of the P1 (8). Likewise, robust deficits
are seen in first-episode patients and in young adults with high
schizotypy, supporting the notion that visual sensory processing
deficits may be related to predisposing genetic risk for the disor-
der rather than progression of the disease state itself (9–12). The
relationship of visual sensory deficits to genetic liability was fur-
ther emphasized in a pair of studies linking them to specific risk
haplotypes for schizophrenia on the dysbindin gene (DTNBP1)
(13) and the nitric oxide synthasase-1 gene (NOS1) (14). Taken
together, these studies point to early visual sensory processing
deficits as a potentially valuable tool in early detection efforts and
to the possibility that this biomarker might expand our abilities
to identify children at risk during the prodromal stages of the
disorder (15, 16).
Dysfunctional neural plasticity is another key aspect of corti-
cal processing implicated in the pathophysiology of schizophrenia
(17, 18). Recently, Cavus and colleagues assessed visual cortical
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plasticity in schizophrenia using an experimental design believed
to be a non-invasive analog of long-term potentiation (LTP) stud-
ies conducted in animal models (18). They used high-frequency
visual stimulation (∼9 Hz) as a form of photic tetanus, as a proxy
for the tetanic electrical inputs used to induce LTP in animals,
since prior work had shown that the amplitude of early VEP com-
ponents was enhanced following high-frequency photic inputs
(19). Cavus showed that the initial C1 component of the VEP was
indeed enhanced in neurotypical adults following photic tetanus,
but no such enhancement was seen in a group of patients with
schizophrenia. In line with the well-established role of the glu-
tamatergic system in LTP induction in animals, they interpreted
their results as evidence for dysfunctional N -methyl-d-aspartate
(NMDA) receptor-mediated plasticity in schizophrenia.
Given the existing evidence for visual sensory processing
deficits and emerging evidence for deficits in visual sensory plas-
ticity, we set out here to more fully explore the intersection of these
two candidate endophenotypes. We asked whether short-term
visual plasticity is compromised in schizophrenia and whether
deficits in plasticity would be related to more fundamental deficits
of sensory transmission. Our measure of plasticity was based
on early work by Tyler and Kaitz (20), who used a monocu-
lar deprivation (MD) paradigm to induce short-term changes in
VEP amplitude. These authors showed that by covering one eye
for several hours, an increase in VEP amplitude was observed
across time for stimulation of the non-occluded eye. That is,
immediately following eye-occlusion, the monocularly derived
VEP amplitude attenuates relative to binocular viewing. This is
unsurprising, of course, since half of the afferent input to the
system has been removed. However, over the following 2–6 h,
the monocularly derived VEP gained significantly in amplitude,
suggesting relatively short-term reorganization of early visual cor-
tical representations to compensate for the missing input. There
is also considerable evidence in the literature for the non-linear
nature of binocular interactions in humans (21–23). That is, when
VEPs elicited from monocular viewing are summed together, the
resultant “synthetic” response is found to be of greater ampli-
tude than the VEP evoked during binocular viewing (i.e., Left-eye
alone+Right-eye alone>Both eyes together). The implication
is that during binocular viewing, there is substantial interaction
between monocular dominance columns, likely due to cross-
inhibitory mechanisms (24). Thus, this paradigm likely assays
short-term plasticity that is mainly driven by changes in GABAer-
gic mechanisms, unlike the study of Cavus and colleagues where
NMDA functioning was the hypothesized synaptic substrate (18).
There is also good reason to expect that there might be specific
impairment of such binocular interactions in schizophrenia (25).
Ocular dominance columns in visual cortex segregate cells that are
selective for left-eye, right-eye, or binocular stimuli (26). While
the exact functional purpose of this columnar organization is not
fully known, it is highly likely that one of its functions is in the
computation of stereopsis, or depth perception, and patients with
schizophrenia show a marked deficit in binocular depth perception
(25), suggesting that interaction of ocular dominance columns
may indeed be compromised.
Here, we utilized an MD paradigm similar to that of Tyler and
Kaitz (20), though a substantially abbreviated version that allowed
us to capture dynamic effects of MD in just 25 min. Developing
tests that are easily administered over a relatively short period
will be essential if these tests are to have genuine clinical utility.
VEPs were recorded from participants while they viewed simple
isolated-check stimuli both binocularly and monocularly. The pre-
dictions were straightforward. Once input to one or the other eye
is occluded (using a simple eye patch), the expectation is that
early VEP amplitude elicited from single-eye viewing will dimin-
ish immediately thereafter, but that a relatively rapid recovery of
amplitude will be evident in the following minutes as the visual
system compensates for missing input. Our proposition is that
this recovery of amplitude results from a basic release from the
inter-ocular inhibition inherent in binocular interactions, and that
dysregulation of this short-term plasticity in schizophrenia will
result in an attenuated VEP. As such, our main hypothesis is that
the rapid recovery of VEPs exhibited by healthy controls under
conditions of MD will be substantially attenuated in patients with
schizophrenia.
MATERIALS AND METHODS
The procedures of this study were approved by the Ethics Com-
mittee of St. Vincent’s Hospital in Fairview, Dublin, and the
Institutional Review Board of the City University of New York.
All procedures were consistent with the ethical standards laid out
in the Declaration of Helsinki. Participants received a modest fee
for taking part in the study.
PARTICIPANTS
Informed consent was obtained from 20 (4 female) patients with
schizophrenia, aged 28–63 (mean= 41.6± 12.2 years), from the
St. Vincent’s Hospital Catchment Area in Fairview, Dublin. The
mean score on the Brief Psychiatric Rating Scale (BPRS) for
the patients was 39.5± 8.6 and for the Scale for the Assess-
ment of Negative Symptoms (SANS) was 33.1± 16.8. Control
participants comprised 20 (4 female) volunteers aged 19–61
(mean= 39.0± 15.2 years). The mean age of patients and con-
trols did not differ significantly (p= 0.48). Seventeen of the 20
patients and 18 of the 20 controls were right-handed as assessed by
the Edinburgh Handedness Inventory (27). All subjects reported
normal or corrected-to-normal vision; where possible, this was
corroborated by medical records. Controls were free of any psy-
chiatric illness or symptoms by self-report using criteria from the
SCID-NP (28).
Patients met the following inclusion/exclusion criteria: inclu-
sion: (1) current DSM-IV-defined diagnosis of schizophrenia. A
best estimate diagnostic approach was utilized in which infor-
mation from the Structured Clinical Interview for DSM-IV Axis
I Disorders (SCID-I/P) (28) was supplemented by information
from family members, psychiatrists, and medical records to gener-
ate a diagnosis, (2) aged between 18 and 65, (3) any race, (4) male
or female, (5) competent and willing to sign informed consent.
Exclusion: (1) organic brain disorder, mental retardation, or sig-
nificant medical illness, (2) current substance-induced psychotic
disorder or a psychotic disorder due to a general medical condition
determined by DSM-IV criteria, (3) significant risk of suicidal or
homicidal behavior, (4) any history of visual impairment beyond
corrected-to-normal vision, (5) any additional Axis I diagnoses.
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Neurotypical controls met the following inclusion/exclusion
criteria: inclusion: (1) absent any current Axis I or Axis II disorder
or mood or psychotic disorder for the last 5 years as assessed by
the SCID-I/NP (i.e., Non-Patient version), (2) matched for age to
patients with schizophrenia and between the ages of 18 and 65,
(3) any race, (4) male or female; (5) competent and willing to sign
informed consent, (6) no current or past history of psychotropic
medication usage, (7) no family history of psychotic illness. Exclu-
sion: (1) organic brain disorder, mental retardation, or significant
medical illness, (2) significant risk of suicidal or homicidal behav-
ior, (3) participants with prior intermittent alcohol or substance
use were not excluded unless they met DSM-IV criteria for current
alcohol or drug dependence in the last 6 months, (4) any history
of abnormal vision beyond corrected-to-normal vision.
For all patients, demographic information was collected (see
Table 1). Symptom ratings were analyzed using the BPRS and the
SANS (29). Doses of anti-psychotic, anti-cholinergic, and adju-
vant medications (e.g., anti-depressants, sedative/hypnotics,mood
stabilizers, anti-convulsants) were recorded. Anti-psychotic doses
were translated into chlorpromazine equivalents using the best
available literature at the time of data analysis for conversion of
dose levels of newer anti-psychotics (e.g., sertindole, seroquel).
A limitation of the present study is that all patients were receiv-
ing medication at the time of testing. However, visual processing
deficits have been found in both medicated and unmedicated
patients [e.g., Ref. (30–33), as well as in (unmedicated) first-
degree relatives of patients with schizophrenia (8)]. Medication
effects, length of illness, and symptom severity should all be
taken into consideration as potential confounds when conduct-
ing research with schizophrenia patients. However, evidence in
the literature supports the notion that these factors do not impact
VEPs generated at such early latencies as the P1 (34).
STIMULI AND TASK
Subjects were seated in a comfortable chair in a dimly illuminated,
sound-attenuated room, and asked to keep head and eye move-
ments to a minimum. In each experimental block, subjects were
presented with∼100 isolated-check images, gray on a white back-
ground (4°× 4° visual angle) at 64% contrast and 40 line drawings
of two kinds of animal (2.4° wide× 1.8° high) on a white back-
ground. A different animal pair was randomly chosen for each
block, from a possible 22. This simple paradigm has been described
extensively in our previous work (9) (see Figure S1 in Supplemen-
tary Material). All subjects completed nine blocks of stimulation,
each lasting 3 min. These consisted of three blocks wherein the
participant viewed stimuli binocularly, followed immediately by
three blocks of occlusion (an eye patch) of one eye, and three
blocks of occlusion of the other eye. After the first monocular
series of three blocks, the patch was switched to the other eye by
the experimenter and stimulus delivery begun again immediately.
The order in which the first eye was occluded (i.e., right or left)
was counterbalanced across participants. Stimuli were presented
centrally on a computer monitor in random order, with the mon-
itor located 160 cm directly in front of the seated subject. The
timing of the presentations was such that each image appeared
for 60 ms with a variable inter-stimulus interval (ISI) between 740
and 1540 ms (randomly in steps of 200 ms) during which there
Table 1 | Demographic and clinical characteristics of schizophrenia
patient group (N =20).
Neuroleptics: atypical/typical/both 12/4/4
Chloropromazine (CPZ)-equivalent±SD, daily (mg) 564±423
Education±SD (using SCID education scale 1–8) 5.1±2
Illness duration±SD 16.1±9
BPRS positive symptom±SD 39.5±9
SANS total all items except global at baseline±SD 33.1±17
Visual hallucinations: past/present/none 4/1/15
was a blank white screen. The target animal was displayed at the
start of the task and subjects were asked to respond each time
this animal was presented by pressing a button with their right
thumb. They were told only to respond to target animals and to
withhold responses to any other animal presented. The target and
non-target animals were presented with equal probability, ensur-
ing that a subject could not rely on the exogenous alerting nature of
any non-checkerboard stimulus to respond. Furthermore, the task
of discrimination was made difficult by pairing similar-looking
animals (e.g., a dolphin and whale). The use of this task ensured
that subjects were actively observing the stimuli. Only ERPs to the
standard checkerboard stimuli were analyzed here.
DATA ACQUISITION AND STATISTICAL ANALYSIS
Continuous EEG was acquired through the ActiveTwo Biosemi™
electrode system from 72 scalp electrodes, digitized at 512 Hz with
an open pass-band from DC to 150 Hz. For analysis and dis-
play purposes, data were subsequently filtered with a 0-phase-shift
40 Hz low-pass filter (24 dB/octave) and baseline corrected after
acquisition. No high-pass filter was applied. With the Biosemi
system, every electrode or combination of electrodes can be
assigned as the “reference,” and this is done purely in software
after acquisition. BioSemi replaces the “ground” electrodes used
in conventional systems with two separate electrodes: common
mode sense (CMS) active electrode and Driven Right Leg (DRL)
passive electrode. These two electrodes form a feedback loop,
which drives the average potential of the subject (the Common
Mode voltage) as close as possible to the ADC reference volt-
age in the AD-box (the ADC reference can be considered as
the amplifier “zero”). For a detailed description of the refer-
encing and grounding conventions used by the Biosemi active
electrode system, the interested reader is referred to the following
website: http://www.biosemi.com/faq/cms&drl.htm. All data were
re-referenced to the nasion after acquisition, for analysis. EEG was
averaged off-line. Data were epoched (−100 ms pre-stimulus to
500 ms post-stimulus) and then averaged. Baseline was defined
as the mean voltage over −100 to 0 ms preceding the onset of
the stimulus. Trials with blinks and large eye movements were
rejected off-line on the basis of horizontal and vertical electroocu-
logram recordings. An artifact rejection criterion of ±100µV was
used at all other electrode sites to exclude periods of high EMG
and other noise-transients. From the remaining artifact-free trials,
averages were computed for each participant. The average accep-
tance rate for the patients was 71± 17.6%, and for the control
group 75± 20.0%. These averages were then visually inspected
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for each individual to ensure that clean recordings with sufficient
numbers of trials were obtained and that no artifacts were still
included. Bad channels were interpolated using BESA software.
Data were ultimately averaged across all subjects (grand mean
averages) within a given group (patient or control) for visual com-
parison at the group level and for display purposes. The reader
should note that throughout this paper,we use the familiar nomen-
clature of the modified 10–20-electrode system to refer to the
positioning of electrode sites (35).
ANALYSIS OF THE P1-DEFICIT
We first sought to ensure that the previously established P1-
deficit in schizophrenia was indeed replicated in the cohort of
patients who participated here. For this analysis, only data from
the binocular condition were considered. We recorded P1 peak
amplitudes on an individual participant basis by surveying across
six pre-determined scalp electrodes: three over the left hemiscalp
(PO7/PO3/O1) and three over the right (PO8/PO4/O2). These
sites were chosen for analysis based on observation of the group-
averaged data (collapsed across patients and controls), since they
best represented the maximal topographic distribution of the
bilateral P1 component, entirely consistent with previous work
(36, 37). Separate composite averages for left (PO7/PO3/O1) and
right (PO8/PO4/O2) hemiscalps were computed for each subject,
and peak amplitude was recorded for each hemiscalp for each
subject at their individual P1 peak latency. We did not exclude
any subject’s P1 on the basis of absolute amplitude; if an obvious
P1-like component was discernible, its value was recorded, and
included in the analysis. However, if a clearly discernible P1 was
not evident over both hemiscalps, then data from that participant
were excluded from this P1 analysis. These peak P1 amplitude
data were then submitted to a mixed design ANOVA with factors
of group (controls vs. patients) and scalp region (left vs. right) to
compare P1 amplitudes.
ANALYSIS OF THE BINOCULAR EFFECT
Having first established that the P1 processing deficit was evident
in this cohort of schizophrenia patients, we then moved to the
assessment of putative binocular interactions. Since research into
binocular interaction effects using VEPs is very sparse, and the
early VEP componentry has not been explicitly interrogated for
such effects (to our knowledge), we had no specific way to pre-
dict precisely when during initial sensory processing we would
see non-linear effects in the data as a function of binocularity.
On the other hand, we reasoned that binocular interactions must
surely occur during the earliest sensory processing time-frame
since work from our group has shown that even trans-colossal
inter-hemispheric interactions are already evident during the P1
processing time-frame (36). Thus, our approach here was to first
identify the earliest binocular effect (BE) in our control cohort,
thereby defining a time-window and appropriate scalp regions
for subsequent between groups analyses. A clear and robust effect
was indeed evident in the group-averaged data from the control
group in the time-frame between 95 and 115 ms. This effect also
had a bilateral occipito-parietal distribution, so average ampli-
tude measures over the 95–115 ms time-frame were derived from
the same six scalp sites (PO7/PO3/O1 over the left hemiscalp and
PO8/PO4/O2 over the right) as used during the P1 analysis. Here,
regardless of whether amplitude values were positive or nega-
tive during the time-frame, data from all 20 controls and all 20
patients were included, since this analysis did not depend on the
identification of any particular ERP component.
The VEP BE was defined here as any deviation from the pre-
dictions of a model that assumed two independent populations
of neurons whose outputs are, in the far field, simply additive.
Monocular responses were added (Left-eye alone “PLUS” Right-
eye alone) to yield the model’s prediction of binocularly evoked
response; this trace was then subtracted from the actual binocular
response to yield a difference trace which is considered to represent
BE, and which we refer to as the “modulation index.” We hence-
forth refer to the summed waveform as SUM, and the binocularly
evoked waveform as BASE.
Amplitude measures taken over the 95–115 ms time-window
from the left and right hemiscalps were then submitted to
a repeated measures ANOVA with between-subjects factor of
group (patients vs. controls) and within-subjects factors of scalp
region (left/right) and condition (SUM vs. BASE). All tests were
two-tailed with a preset α-level of p< 0.05.
Following our primary analyses of P1 amplitude and the BE,
it was of interest to further investigate spatio-temporal properties
of any potential differences between groups, using the statisti-
cal cluster plot method. This procedure has been used effectively
in post hoc analyses as a means to more fully explore complex
datasets and generate pointed follow-up hypotheses (38, 39). For
each group, point-wise two-tailed Student t -tests (between condi-
tions) were calculated at each time-point for all electrodes, and a
color map was subsequently generated marking time-points on
each electrode for which the t -value exceeds that correspond-
ing to a 0.05 p-value. Importantly, the use of this approach is
limited to that of a hypothesis-generation tool. Here, it simply
provided a visualization tool providing confirmatory evidence.
Periods of significant difference are only plotted if an alpha cri-
terion of <0.05 was exceeded for at least 10 consecutive data
points (40).
Finally, in order to test whether a relationship between P1
amplitudes and the BE could be detected, we conducted corre-
lation analyses. The main goal here was to assess whether those
patients with the greatest P1-deficits were those who also showed
the lowest binocular modulation index – that is, to assess whether
the BE and P1 generation might be related. A correlation coef-
ficient was computed for P1 amplitudes (collapsed averages for




In the binocular, left-eye alone, and right-eye alone conditions,
the mean target hit rates were all >80% and did not significantly
differ between control participants and patients. These rates of
performance indicate that all participants were actively observing
the stimuli throughout the experimental blocks. Recall that target
stimuli are not entered into the main analyses here, serving purely
to maintain participants’ attention throughout the experimental
blocks. No motor responses were recorded to the isolated-check
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stimuli that served as standards and that were explicitly analyzed
in what follows.
REPLICATING THE VISUAL P1-DEFICIT
We begin with an analysis of the P1 component. The P1 peak for
the control group in the binocular condition was found at∼93 ms,
and was maximal over bilateral parieto-occipital and occipital
regions with entirely typical topography (37). In patients, the P1
peak was found at 97 ms over the same regions (see Figure 1).
A mixed 2× 2 ANOVA was conducted with a between-subjects
factor of group (patients vs. controls) and a within-subjects factor
of hemiscalp (left vs. right). The P1 peak was identified at each
site for each participant1, and an average of the three electrodes
was calculated for each hemiscalp. A main effect of group was
observed (F(1,31)= 7.148, p= 0.01), as was a significant inter-
action of group by hemiscalp (F(1,31)= 4.794, p= 0.036). To
further examine the interaction between group and hemiscalp,
protected follow-up t -tests were carried out for each hemiscalp
separately. A significant difference was found between controls
and patients over both the left (p= 0.01) and the right (p= 0.002)
hemiscalps. For controls, the average P1 amplitude on the left was
5.92± 2.67µV, on the right 6.72± 2.90. For patients, these values
were 3.59± 2.51 (left) and 3.35± 2.51 (right). As such, the inter-
action was driven by the fact that the difference between groups
was greater over the right hemiscalp than the left. Figure S2 in
Supplementary Material shows a scatterplot of P1 amplitudes (col-
lapsed across left and right hemifields) to better illustrate the group
differences. A comparison of these latter values (i.e., collapsed
1In four control participants and four patients, a clear P1 could be identified over
only one hemiscalp. The hemiscalp of absent P1 was not consistent across subjects.
These subjects were excluded from this P1 2× 2 ANOVA.
across hemiscalps) also revealed a significant difference between
groups (t (15)= 2.43, p= 0.028) with a large effect size (Cohen’s
d = 1.05).
THE BINOCULAR EFFECT: CHARACTERIZING INTER-OCULAR PLASTICITY
By visually examining the ERPs of both groups over parieto-
occipital scalp, we observed a striking non-linearity in the control
group for their summed VEPs (left-eye alone+ right-eye alone,
or SUM) compared to their binocularly evoked VEPs (BASE) (see
Figure 1). We termed this non-linearity the “binocular effect.”
To explore potential group differences in the BE, a 2× 2× 2
ANOVA was performed with factors of group (patients vs. con-
trols), condition (BASE vs. SUM) and hemiscalp (left vs. right) for
amplitude measures over the 95–115 ms time period. A significant
interaction of group by condition was found (F(1,38)= 4.526,
p= 0.04). Follow-up protected t -tests revealed a significant effect
of condition over both the left and right occipital scalp in con-
trols (p= 0.002 and p= 0.034, respectively). Patients on the other
hand, failed to exhibit a significant effect of condition over either
hemiscalp (p= 0.93 and p= 0.90).
Figure 2 displays the modulation index. Each point on the scat-
terplot represents a participant’s single value for SUM minus BASE
(collapsed over hemiscalps), thereby providing a snapshot of the
degree to which each subject exhibited the BE. The reader will
note in Figure 2 that there is one patient who could be considered
an outlier, with a modulation index of approximately −20µV. To
ensure that our results were not adversely affected by inclusion
of this participant’s data, we also analyzed the data excluding this
participant. The main effect of group remained significant with
large effect size (d = 0.59).
Figure 3 displays subtraction waveforms (SUM minus BASE)
to illustrate the BE in both controls and patients. These subtraction
FIGURE 1 | Waveforms from two representative parieto-occipital scalp sites (PO3 and PO4) are shown for neurotypical control participants and
patients with schizophrenia. (A) Data from 20 control subjects are displayed in pink and blue; (B) data from 20 patients are displayed in red and green.
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waveforms, taken from representative occipito-parietal electrode
sites (PO3 and PO4) emphasize the robust BE in controls (red
trace) that emerges between ∼90 and 120 ms. This difference is
much less pronounced in patients (green trace). It can also be
seen that later differences between SUM and BASE (from 150 ms
onward), while evident in the subtraction waveforms of patients,
are also of lower amplitude than those seen in controls (analyzed
below).
Correlation analysis was conducted to assess whether a relation-
ship between P1 amplitudes and the BE could be detected (that is,
if those patients with the greatest P1-deficits were those who also
showed the weakest binocular modulation index). This analysis
revealed no correlation in the healthy control group (r =−0.26;
p= 0.165), whereas a significant positive correlation between these
two measures was found for the patients (r = 0.515; p= 0.02).
Correlation scatter plots for patients and controls are overlaid in
Figure 4.
FIGURE 2 | Modulation index for the binocular effect: each point in the
scatter plot represents the data for one participant. Values were derived
by subtracting Binocular (BASE) from SUM conditions. Controls are shown
in blue, patients in red. Using Cohen’s d, the effect size of the difference is
0.67.
Following the logic of a multivariate endophenotype as
described by Price et al. (41), we combined our two metrics,
P1 amplitude and the binocular modulation index, to determine
whether this would result in a greater overall effect size. Our
hope was that taken in concert, these measures would provide
better group classification than when taken in isolation. Under
this approach, the two metrics were first treated individually as
independent variables, with subjects as our dependent variable.
Univariate logistic regression (cut 0.5) was used to determine a
regression model that maximally separated patient and control
groups on the basis of each feature alone. In turn, multivariate
logistic regression (cut 0.5) was then used to develop a com-
posite regression model that was compared with the univariate
models. P1 amplitude predicted group membership with 71.9%
accuracy, the BE modulation index with 65.6%, and both measures
taken together were 75% accurate as predictors. Full results of the
analyses are displayed in Table 2.
In Figure 5, the statistical cluster plots display between-
condition differences (BASE vs. SUM) for each group. Examina-
tion of these plots made clear that there were four major clusters
FIGURE 4 | Scatter plot is displayed showing correlations for each
subject of P1 amplitude to modulation index. The x -axis displays
values for P1 amplitudes; y -axis displays binocular modulation indices.
The P1 values used here are collapsed averages of left and right
hemiscalp amplitudes. Controls are depicted by blue points (n=16),
patients by pink (n=16).
FIGURE 3 |The binocular effect is characterized with difference waveforms (SUM minus BASE) for controls (red) and patients (green) at two
representative electrodes (PO3 and PO4). The yellow shading denotes the early “binocular effect” period.
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Table 2 | Coefficients of univariate logistic regression models that were evaluated: univariate models for two features, then a multivariate model
incorporating both features.
Model predictor B SE Wald statistic df p Exp (B) Overall predictor value (%)
P1 amplitude −0.394 0.165 5.735 1 0.017 0.674 71.9
P1 constant 1.841 0.838 4.830 1 0.028 6.304
Binoc effect −0.139 0.073 3.585 1 0.058 0.871 65.6
Binoc effect constant 0.462 0.474 0.950 1 0.330 1.588
Multivariate P1 amp 0.364 0.167 4.763 1 0.029 1.440 75
Multivariate binoc effect 0.127 0.081 2.460 1 0.117 1.135
All models were generated based on data from 16 patient and 16 control participants.
FIGURE 5 | Statistical cluster plots depict point-wise running t -tests
comparing the amplitudes of participants’ VEPs in Binocular vs. SUM
conditions. Time with respect to stimulus onset is presented on the x -axis
and the general topographic regions of 72 electrode positions are displayed
on the y -axis. Color corresponds to t values. Periods of significant
difference are only plotted if a strict alpha criterion of <0.05 was exceeded
for at least 10 consecutive data points. The early “binocular effect” period
has been outlined with a black box for each group.
of interest. The first of these was, of course, the one of primary
interest to us, as it encapsulated the BE. This is highlighted with a
black box in Figure 5. In controls, this cluster emerged at∼90 ms,
and was restricted largely to posterior scalp (i.e., parietal, parieto-
occipital, and occipital regions). In patients, effects in this period
were notably absent; consistent with the complete absence of any
BE in patients as discussed above.
Although not directly related to our primary period of inter-
est, we include here a full description of subsequent clusters of
significance identified by this analysis. The second significance
cluster emerges for both groups at ∼140–160 ms. A compari-
son with waveforms shows this cluster to correspond generally
with the N1 component for both groups (see Figure 1), and
the effect appears largely similar for both groups. A third pro-
nounced cluster onsets at ∼200 ms; waveform comparison shows
that this cluster corresponds to the first of two broad positive
components elicited in both groups. Whereas this significance
cluster in patients is largely confined to central, parietal, and
occipital regions, in controls it may also extend more frontally.
The cluster plots show that this effect is robust for both groups,
although it is also clear that it is more so the case in controls.
The final cluster is a much more broadly distributed effect that
appears to have its onset between 200 and 300 ms and extends
to the end of the sampled epoch. In controls it is less distinct as
a separable cluster than in patients, but again comparing cluster
plots to waveforms (Figure 1) revealed that this is largely coinci-
dent with the final positivity, onsetting between 200 and 300 ms.
Again, the cluster plots show that differences between SUM and
BASE waveforms are considerably more robust in controls than
patients. We were interested to determine whether these later
two periods would show significant group by condition inter-
actions and therefore submitted these time-windows to a pair
of post hoc ANOVAs. For the 200–300 ms period, a main effect
was found for condition (F(1,38)= 78.636, p< 0.001), but not for
group (F(1,38)= 0.414, p= 0.524). A group by condition interac-
tion did not attain conventional levels of significance although a
trend is evident (F(1,38)= 3.495, p= 0.069), and this effect may
represent a good candidate for future investigation and replica-
tion. We also tested both groups for the time period 300–400 ms;
here, main effects of group (F(1,38)= 7.774, p= 0.008) and
condition (F(1,38)= 11.131, p= 0.002) were found, but there was
no significant interaction of group by condition (F(1,38)= 0.883,
p= 0.354).
DISCUSSION
We set out to develop a simple-to-execute test of short-term visual
sensory plasticity and to assess whether this plasticity was intact
in schizophrenia. A basic MD task allowed for assessment of
sensory-level binocular integration. We reasoned that if patients
with schizophrenia showed deficits in this plasticity, this would
provide further evidence for fundamental visual sensory process-
ing deficits in this population and might explain previous work
showing deficits in depth perception (25). We first replicated the
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well-established P1-deficit in our patient sample, again with a
large effect size. In terms of the BE, while patients exhibited a
significant decrement, the effect size achieved was only in the
medium range (0.67). Correlation analysis suggested that those
patients with the weakest BE were those patients also showing the
greatest P1-deficit. Coupled with the complete lack of correlation
between these metrics in controls, this finding is intriguing. First,
the absence of any relationship between P1 amplitude and the BE
in controls suggests that separable processes drive them. This dis-
sociability is emphasized by the fact that the P1 and the BE have
quite different, albeit overlapping, timecourses. Why then do we
find significant correlation in the patients? The implication is that
both metrics index a more general set of visual processing deficits
in this population. It bears mentioning, however, that data from
only 16 patients were entered into this correlation analysis and
that replication will be important before strong conclusions can
be drawn.
From a diagnostic perspective, it would be highly useful if the
P1-deficit and the BE could both be identified as endopheno-
typic. While evidence is strong that this is so for the P1-deficit,
it remains to be seen whether the same is true of the BE. One
of our main motivations here stemmed from the notion that
by combining these two easily obtained metrics as part of a so-
called multivariate endophenotype (15, 41, 42), we might improve
classification ability. However, combining P1 and the BE in this
relatively small cohort was disappointing, in that the ability of
a combined measure to correctly classify patients and controls
increased only modestly from 71.9 to 75% when the P1 was used
in isolation. Nonetheless, modest classification improvement such
as this may yet prove useful when a greater number of endopheno-
typic measures are combined, especially if measures across sensory
modalities are employed (43).
While inter-individual variance of the BE precludes its use as a
single clinical marker, it may yet prove useful for future research to
parse deficits in basic sensory processing with an intra-individual
strategy in mind. For example, since patients with schizophrenia
have shown impaired binocular depth perception (25), it could
well be the case that a closer examination of the patients in the
present study whose modulation index was the lowest would reveal
a specific profile of visual sensory impairment that could enable
us to begin to tease apart some fundamental trait-level process-
ing deficits. This, in turn, may allow us to classify a sub-group of
patients that share specific risk genetics. It may be the case that
those patients who failed to show the BE (i.e., had a modulation
index of zero or less) are also those individuals who lack stere-
opsis, although this remains to be explicitly tested. Further, there
may be a link between these deficits and deficits of the visual bio-
logical motion processing system, which also shows impairments
in schizophrenia (44). Linking a cluster of subclinical traits such
as these together may prove valuable in allowing us to target the
presence of schizophrenia in a prodromal population. Even weakly
endophenotypic markers for schizophrenia could still prove use-
ful as elements of a battery of metrics for risk assessment. That is,
compilation of a set of measures, some with high sensitivity but
low specificity and others with high specificity but low sensitivity,
may prove to be an excellent multivariate strategy for assessing
risk (41).
There is precedence for manipulating short-term dynamic
changes in visual processing as a means to investigate psychiatric
illness. For example, Pettigrew and Miller (45) employed binocu-
lar rivalry to examine the neuropathology of bipolar disorder [also
Ref. (46)]. Binocular rivalry occurs when two different images are
presented to each eye simultaneously. Observers perceive either
one or the other image alternating between the right and left-eye
inputs, and these perceptual switches occur automatically. Petti-
grew and Miller found that bipolar patients had slower perceptual
switches than controls and they attributed this to what they termed
“sticky” inter-hemispheric switches. It is noteworthy that we also
found visual P1-deficits in euthymic bipolar patients that mimic
those seen in schizophrenia (47), suggesting that the P1-deficit, and
binocular interaction anomalies, may result from shared genetic
risk for psychotic disorders more generally.
POTENTIAL SYNAPTIC MECHANISMS OF BINOCULAR INTERACTIONS
AND MONOCULAR PLASTICITY
In the one existing study to assess short-term visual plastic-
ity in schizophrenia, high-frequency photic inputs were used to
enhance/tetanize early visual responsiveness, a paradigm expressly
developed to assay putative glutamatergic dysfunction (18). When
one considers the potential neurochemical mechanisms of the
plasticity revealed by the current paradigm, the bulk of the work
on interactions between ocular dominance columns points to pri-
mary involvement of the GABAergic system (48, 49) rather than
the glutamatergic system, although the picture is surely more com-
plicated than a single transmitter system. The majority of what
is known about the effects of MD derives from animal models,
almost exclusively involving long-term deprivation preparations
(49–53). Early seminal work by Wiesel and Hubel (54) observed
that MD in kittens induced a shift in ocular dominance toward the
non-deprived eye, an effect also shown subsequently in adult mice
(53). By iontophoretically applying the GABA antagonist bicu-
culline to visual cortical neurons in area V1 of cats monocularly
deprived from birth, Burchfiel and Duffy showed that input from
the deprived eye could be restored in a large percentage of V1 neu-
rons (48). Their work implied that cells representing the deprived
eye were constitutively and strongly inhibited by those represent-
ing the non-deprived eye. Work has also suggested that ocular
dominance plasticity is dependent on the strength of GABAergic
inhibition relative to glutamatergic excitation [reviewed in Ref.
(52)]. Mower and Christen (49) showed an “enhanced” role of
GABA in animals with abnormal ocular dominance. In cats raised
with MD, 50% of visual cortical neurons showed changes in ocu-
lar dominance after GABA antagonist administration compared
to only 17% of neurons in normal cats.
Here, of course, we used a much shorter-term deprivation par-
adigm, measured over a matter of minutes rather than hours and
days and the effects we observed were fast-acting. One possibil-
ity here is that once input is temporarily removed from one eye,
that there is a release from inter-ocular inhibition of the other
eye, and that the changes we measure in our control populations
represent this fast-acting change in GABAergic functioning. By
inference then, the lack of a BE would signal GABAergic dysfunc-
tion in schizophrenia, and it is of significant interest to note that
a relatively recent magnetic resonance spectroscopy (MRS) study
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reported significantly reduced GABA concentrations in the visual
cortex of patients with schizophrenia (55). Yoon and colleagues
also showed a significant relationship between MRS measures
of GABA and performance levels on an orientation-specific sur-
round suppression judgment task. This task asks participants to
determine whether there is a lower contrast target segment in
a multi-segment surface and is believed to rely on GABAergic
inhibitory surround mechanisms in visual cortex. That patients’
performance on the task was considerably impaired and that per-
formance across patients and control participants was related to
GABAergic mechanisms clearly implicates GABA in the visual
sensory dysfunctions that are now consistently being observed
in schizophrenia. Nonetheless, other possibilities should be con-
sidered with regard to the results of the current study, and one
of these is that the release from inter-ocular inhibition may also
be accompanied by short-term NMDA-based increases in synap-
tic efficacy within the ocular dominance columns still receiving
inputs. Clearly, it will fall to future research efforts to expressly test
these possibilities, likely involving direct pharmacological manip-
ulations, and it bears emphasizing that the current study supports
only speculations about the underlying synaptic mechanisms since
our non-invasive techniques simply cannot directly assess function
at this level.
STUDY LIMITATIONS AND FUTURE CONSIDERATIONS
Participants in this study were all receiving anti-psychotic med-
ications at time of testing and one needs to consider the possible
effects of such on the recorded VEPs. It would be ideal to repli-
cate these findings in drug-naïve first-episode patients and to
assess whether short-term visual plasticity deficits are also present
in first-degree biological relatives, which would circumvent this
medication issue. However, it is important to point out that the
visual sensory processing deficits seen in the VEP of schizophrenia
patients (i.e., the P1 amplitude decrement) are also found in both
unmedicated patients and their first-degree relatives (8, 9) and
the extent of the P1-deficit was not correlated with anti-psychotic
dosage levels in a large-cohort patient study (9). As such, we con-
sider it unlikely that the current effects are related to medication
status. Another limitation here is the lack of a behavioral correlate
with the observed plasticity deficits. As mentioned above, it would
be of significant interest to assess whether weakened monocular
plasticity relates to the extent of previously observed stereopsis
deficits in schizophrenia (25).
Another consideration relates to how potential attentional dif-
ferences between groups might play a role in the deficits observed
here. There is certainly considerable work pointing to attention-
related deficits in schizophrenia (56–58) and VEP work has shown
that the P1 component is modulated by shifts in spatial atten-
tion (59–61). However, differences in attentional deployment seem
an unlikely explanation for a number of reasons. First, there was
no difference in how patients with schizophrenia performed the
target detection task relative to controls, and the checkerboard
stimuli themselves were not explicitly attended by either group
since the task was to respond to occasionally occurring pictures
of animals. Second, while spatial attention can modulate the P1
evoked to more peripherally presented inputs, a number of stud-
ies have shown that when inputs are presented to central fixation,
modulation of early VEP components as a function of selective
attention is not observed (62, 63). The basic notion is that suddenly
onsetting visual inputs to the fovea always receive fully elaborated
sensory processing, although it bears pointing out that modest
modulations of the P1 can be observed when continuous central
stimulation routines are employed and covert spatial attention is
deployed toward peripheral events (64). Here, however, the fact
that patients were successfully completing the central task makes
it clear that they were not consistently attending to peripheral
space (where nothing was happening), and even if they somehow
were, previous VEP work shows that this would not have resulted
in a P1 modulation. Finally, while there is evidence for visuospa-
tial attention deficits in patients with schizophrenia, recent work
by Hahn and colleagues shows that these deficits only manifest
under conditions where relatively complex spatial arrays are used.
They used a design where there were four potential peripheral
target locations and found that if they spatially cued just one or
two locations on a given trial, patients showed the same perfor-
mance benefits in responding to validly cued targets vs. targets
that appeared at uncued locations. However, when the number of
cued locations increased to four, the patients now showed deficits
in performance relative to controls. In the current study, there was
only one location used and as above, there was no requirement to
shift spatial attention.
While the P1 is an accepted index of early sensory processing,
it could reasonably be asked why an even earlier VEP compo-
nent, the C1, was not explicitly assayed here. Again, prior work
by our group has shown evidence for deficits in this component
in patients with schizophrenia. A key aspect of the C1 is that it is
known to be generated in early retinotopic cortex (i.e., V1 and V2)
since it reverses in polarity dependent on whether visual inputs are
presented to the upper or lower visual fields and in its projection
to the scalp dependent on whether inputs are presented to the left
or right of fixation (65, 66). Here, we used central presentations,
which by definition lead to activation of all four quadrant rep-
resentations of space in area V1. Given the cruciform geometric
arrangement of the four V1 quadrants, the general effect is for
these four generators to cancel each other out to a large extent
as this arrangement leads to a macroscopic “closed field.” As can
be seen in the waveforms of Figure 1, there is very little evidence
of a C1, as one would expect for our central presentations. Also,
the use of the statistical cluster plot method in post hoc analy-
sis would have revealed possible effects of the main manipulation
of this experiment if they were indeed to be seen during the C1
time-frame, but as can be seen in Figure 5, no effects are evident
before 100 ms. A comprehensive investigation of the C1 compo-
nent in schizophrenia is certainly merited, but such a study would
require explicit methods to individually map the retinotopic pro-
jections at the individual participant level, a method that has been
successfully applied in neurotypical observers (61).
Finally, inspection of the waveforms of Figure 1 reveals a
number of interesting between group differences that will merit
follow-up in future studies. The reader will note that during the
time-frame of the N1 component (circa 120–180 ms), control par-
ticipants show a biphasic pattern of negative waves, whereas the
pattern in patients is monophasic. We have no hypothesis regard-
ing this unanticipated effect, but this difference will clearly merit
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replication and a fuller exploration in future work. Similarly, the
patient waveforms show a distinct negative-going slow potential
that appears to be related to some anticipatory mechanisms since it
precedes stimulus onset, whereas the controls show little evidence
of such anticipatory potentials. The reader will recall that a very
wide range of inter-stimulus-intervals was used between instances
of the checkerboard stimulus (740–1540 ms). As such, the stim-
uli were not rhythmic, as is often the case in studies such as this,
and it is therefore somewhat surprising to see anticipatory poten-
tials. Given the low probability of a target stimulus and the lack
of predictable timing in the sequence, the deployment of anticipa-
tory mechanisms could be considered maladaptive. Nonetheless,
patients performed the task at a high degree of accuracy, so their
strategy appears to have been effective. Again, it will bear follow-
ing up in a specifically designed study to see whether patients with
schizophrenia deploy anticipatory mechanisms in a sub-optimal
fashion. It is key to point out, however, that this negative-going
effect does not impact the main comparison of interest in the cur-
rent study, where our primary hypothesis related to the difference
between the monocular and binocular conditions (i.e., the BE).
It is clear from Figure 1 that these anticipatory potentials are not
driving the differences seen during the P1 time-frame and the sub-
traction waves of Figure 3 show that the early BE occurs in a much
higher frequency band.
CONCLUSION
We developed a simple MD paradigm to assay short-term plasticity
within early visual cortices during the initial sensory process-
ing time-frame. Our overarching hypothesis was that short-term
compensatory mechanisms in the visual system of neurotypical
controls would allow for a relatively rapid recovery of VEP ampli-
tude during periods of MD, but that this rapid plasticity would
be less effectively engaged in patients with schizophrenia. Con-
trols exhibited a robust BE; that is, when we added the evoked
response elicited from viewing with one eye to that of the other
eye and compared this sum to the response resulting from stimu-
lation of both eyes together, we observed a non-additive response.
Compensatory mechanisms related to ocular dominance plastic-
ity were likely engaged to “boost” the response to inputs from
the non-occluded eye. Patients with schizophrenia, on the whole,
failed to exhibit this BE, suggesting that the same process of corti-
cal plasticity that allowed controls to generate robust VEPs in the
absence of input from both eyes was not appropriately invoked in
this population. This simple assay of plasticity in the visual system
may serve as a useful endophenotype for schizophrenia in future
studies.
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Figure S1 |The centrally presented visual stimuli used in the task.
Event-related potential waveforms were derived for the isolated-check
non-target stimulus (A) while target discrimination was performed on the basis
of infrequently presented animal line drawings (B) and (C).
Figure S2 |The scatter plot displays P1 amplitude for each participant;
averages were taken after collapsing over left and right hemiscalp
electrodes. Controls’ values are shown in blue (n= 16), patients in red (n= 16).
The average of the controls’ P1 amplitude was 6.33µV; patients’ was 3.34µV.
The effect size of the difference (using Cohen’s d ) is 1.05.
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